Radiomics: Getting Our ‘Omics from Imaging @ MSOB Conference Room X275
Presenter: Hugo Aerts, PhD Assistant Professor Harvard Medical School Dr. Aerts is an Assistant Professor at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School, and is the lead of a group of[...]
Gastroenterology and Hepatology: Gastroenterology Motility Symposium @ Tressider Oak Lounge | Stanford | California | United States
The Division of Gastroenterology and Hepatology presents: Gastroenterology Motility Symposium Functional gastrointestinal and motility disorders are the most common GI disorders that affect the general population and drive patients to seek medical care. Symptoms related[...]
The Division of Gastroenterology & Hepatology Department of Medicine Stanford University School of Medicine Presents Emmet B. Keeffe Liver Symposium   “Insulin Resistance and Non-Alcoholic Fatty Liver Disease”   Friday, March 9, 2018, 10:00 am[...]
BMIR Research Colloquium: Sandy Napel  “Radiomics: Tools and Techniques” @ MSOB, Conference Room X-275 | Palo Alto | California | United States
Sandy Napel, PhD, Professor of Radiology,Co-Division-Chief, Integrative Biomedical Imaging Informatics at Stanford (IBIIS)Co-Director, Radiology 3DQ Lab Abstract: Radiomics is a process that extracts a feature vector of quantitative metrics to describe an image or a part[...]
Medicine Grand Rounds: Gastroesophageal Reflux Disease in 2018: Diagnosis, Treatment & Controversies @ LKSC Berg Hall | Palo Alto | California | United States
Presenter: John Clarke, MD Clinical Associate Professor of  Gastroenterology and Hepatology                                            Stanford University Dr.[...]
BMIR Research in Progress: Martin Vallières, PhD  “Radiomics: the Image Biomarker Standardisation Initiative (IBSI)” @ MSOB Conference Room X275
Martin Vallières, PhD Postdoctoral Fellow, Medical Physics Unit, McGill University, Cedar Cancer Centre, Montréal Canada ABSTRACT: It is now recognized that intratumoral heterogeneity is associated with more aggressive tumor phenotypes leading to poor patient outcomes. Medical[...]